252 related articles for article (PubMed ID: 16037389)
1. Neutrophil stimulation with Mycobacterium bovis bacillus Calmette-Guerin (BCG) results in the release of functional soluble TRAIL/Apo-2L.
Kemp TJ; Ludwig AT; Earel JK; Moore JM; Vanoosten RL; Moses B; Leidal K; Nauseef WM; Griffith TS
Blood; 2005 Nov; 106(10):3474-82. PubMed ID: 16037389
[TBL] [Abstract][Full Text] [Related]
2. Neutrophils and TRAIL: insights into BCG immunotherapy for bladder cancer.
Simons MP; Nauseef WM; Griffith TS
Immunol Res; 2007; 39(1-3):79-93. PubMed ID: 17917057
[TBL] [Abstract][Full Text] [Related]
3. Identification of the mycobacterial subcomponents involved in the release of tumor necrosis factor-related apoptosis-inducing ligand from human neutrophils.
Simons MP; Moore JM; Kemp TJ; Griffith TS
Infect Immun; 2007 Mar; 75(3):1265-71. PubMed ID: 17194806
[TBL] [Abstract][Full Text] [Related]
4. Interferon-activated neutrophils store a TNF-related apoptosis-inducing ligand (TRAIL/Apo-2 ligand) intracellular pool that is readily mobilizable following exposure to proinflammatory mediators.
Cassatella MA; Huber V; Calzetti F; Margotto D; Tamassia N; Peri G; Mantovani A; Rivoltini L; Tecchio C
J Leukoc Biol; 2006 Jan; 79(1):123-32. PubMed ID: 16244105
[TBL] [Abstract][Full Text] [Related]
5. Plasmacytoid dendritic cell-derived IFN-alpha induces TNF-related apoptosis-inducing ligand/Apo-2L-mediated antitumor activity by human monocytes following CpG oligodeoxynucleotide stimulation.
Kemp TJ; Elzey BD; Griffith TS
J Immunol; 2003 Jul; 171(1):212-8. PubMed ID: 12817000
[TBL] [Abstract][Full Text] [Related]
6. Tumor necrosis factor-related apoptosis-inducing ligand: a novel mechanism for Bacillus Calmette-Guérin-induced antitumor activity.
Ludwig AT; Moore JM; Luo Y; Chen X; Saltsgaver NA; O'Donnell MA; Griffith TS
Cancer Res; 2004 May; 64(10):3386-90. PubMed ID: 15150089
[TBL] [Abstract][Full Text] [Related]
7. Smac mimetic enables the anticancer action of BCG-stimulated neutrophils through TNF-α but not through TRAIL and FasL.
Jinesh G G; Chunduru S; Kamat AM
J Leukoc Biol; 2012 Jul; 92(1):233-44. PubMed ID: 22517918
[TBL] [Abstract][Full Text] [Related]
8. Role of neutrophils in BCG immunotherapy for bladder cancer.
Simons MP; O'Donnell MA; Griffith TS
Urol Oncol; 2008; 26(4):341-5. PubMed ID: 18593617
[TBL] [Abstract][Full Text] [Related]
9. Clostridium butyricum MIYAIRI 588 shows antitumor effects by enhancing the release of TRAIL from neutrophils through MMP-8.
Shinnoh M; Horinaka M; Yasuda T; Yoshikawa S; Morita M; Yamada T; Miki T; Sakai T
Int J Oncol; 2013 Mar; 42(3):903-11. PubMed ID: 23354042
[TBL] [Abstract][Full Text] [Related]
10. Bacillus Calmette-Guerin immunotherapy for urothelial carcinoma of the bladder.
Kresowik TP; Griffith TS
Immunotherapy; 2009 Mar; 1(2):281-8. PubMed ID: 20046960
[TBL] [Abstract][Full Text] [Related]
11. Regulation of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) and TRAIL receptor expression in human neutrophils.
Kamohara H; Matsuyama W; Shimozato O; Abe K; Galligan C; Hashimoto S; Matsushima K; Yoshimura T
Immunology; 2004 Feb; 111(2):186-94. PubMed ID: 15027904
[TBL] [Abstract][Full Text] [Related]
12. Human B cells express functional TRAIL/Apo-2 ligand after CpG-containing oligodeoxynucleotide stimulation.
Kemp TJ; Moore JM; Griffith TS
J Immunol; 2004 Jul; 173(2):892-9. PubMed ID: 15240676
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous blocking of human Toll-like receptors 2 and 4 suppresses myeloid dendritic cell activation induced by Mycobacterium bovis bacillus Calmette-Guérin peptidoglycan.
Uehori J; Matsumoto M; Tsuji S; Akazawa T; Takeuchi O; Akira S; Kawata T; Azuma I; Toyoshima K; Seya T
Infect Immun; 2003 Aug; 71(8):4238-49. PubMed ID: 12874299
[TBL] [Abstract][Full Text] [Related]
14. Cell Death Inhibiting RNA (CDIR) modulates IFN-gamma-stimulated sensitization to Fas/CD95/Apo-1 and TRAIL/Apo-2L-induced apoptosis.
Shchors K; Yehiely F; Deiss LP
Cell Cycle; 2004 Dec; 3(12):1606-11. PubMed ID: 15611657
[TBL] [Abstract][Full Text] [Related]
15. Role of apoptosis-regulating signal kinase 1 in innate immune responses by Mycobacterium bovis bacillus Calmette-Guérin.
Yuk JM; Shin DM; Yang CS; Kim KH; An SJ; Rho J; Park JK; Jo EK
Immunol Cell Biol; 2009 Jan; 87(1):100-7. PubMed ID: 18852704
[TBL] [Abstract][Full Text] [Related]
16. IFNalpha-stimulated neutrophils and monocytes release a soluble form of TNF-related apoptosis-inducing ligand (TRAIL/Apo-2 ligand) displaying apoptotic activity on leukemic cells.
Tecchio C; Huber V; Scapini P; Calzetti F; Margotto D; Todeschini G; Pilla L; Martinelli G; Pizzolo G; Rivoltini L; Cassatella MA
Blood; 2004 May; 103(10):3837-44. PubMed ID: 14726404
[TBL] [Abstract][Full Text] [Related]
17. Pretreatment with paclitaxel enhances apo-2 ligand/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of prostate cancer cells by inducing death receptors 4 and 5 protein levels.
Nimmanapalli R; Perkins CL; Orlando M; O'Bryan E; Nguyen D; Bhalla KN
Cancer Res; 2001 Jan; 61(2):759-63. PubMed ID: 11212279
[TBL] [Abstract][Full Text] [Related]
18. Induction of apoptosis in glioma cell lines by TRAIL/Apo-2l.
Wu M; Das A; Tan Y; Zhu C; Cui T; Wong MC
J Neurosci Res; 2000 Aug; 61(4):464-70. PubMed ID: 10931534
[TBL] [Abstract][Full Text] [Related]
19. TLR2 but not TLR4 signalling is critically involved in the inhibition of IFN-gamma-induced killing of mycobacteria by murine macrophages.
Arko-Mensah J; Julián E; Singh M; Fernández C
Scand J Immunol; 2007 Feb; 65(2):148-57. PubMed ID: 17257219
[TBL] [Abstract][Full Text] [Related]
20. The role of neutrophils and TNF-related apoptosis-inducing ligand (TRAIL) in bacillus Calmette-Guérin (BCG) immunotherapy for urothelial carcinoma of the bladder.
Rosevear HM; Lightfoot AJ; O'Donnell MA; Griffith TS
Cancer Metastasis Rev; 2009 Dec; 28(3-4):345-53. PubMed ID: 19967427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
